A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma (AGuo)
Sponsor and Collaborators Chinese Academy of Medical Sciences Beijing University of Chinese Medicine China Medical University, China Peking Union Medical College Hospital Tianjin Medical University Shanghai Jiao Tong University School of Medicine Changhai Hospital Zhejiang University Fudan University Jiangsu Province Centers for Disease Control and Prevention Central South University Sichuan University Huazhong University of Science and Technology
Contact China Academy of Medical Sciences Jianhui Ma China Academy of Medical Sciences 01086108778
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.